APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Computational Toxicology Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Computational Toxicology Solutions Market Outlook and Growth Opportunities 2026

Report ID 173760910419 December 2025196 pages

Choose your research edition.

Industry ResearchComputational Toxicology Solutions Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Computational Toxicology Solutions Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Computational Toxicology Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Computational Toxicology Solutions Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Computational Toxicology Solutions Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Computational Toxicology Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Computational Toxicology Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Computational Toxicology Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Computational Toxicology Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Computational Toxicology Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Computational Toxicology Solutions market include Instem (Leadscope), Lhasa Limited, MultiCASE, Inotiv, Simulations Plus Inc, Schrodinger, Aclaris, Evogene and Deciphex (Patholytix), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Computational Toxicology Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Computational Toxicology Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Computational Toxicology Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Computational Toxicology Solutions market.

Computational Toxicology Solutions Segment by Company

Instem (Leadscope)

Lhasa Limited

MultiCASE

Inotiv

Simulations Plus Inc

Schrodinger

Aclaris

Evogene

Deciphex (Patholytix)

Exscientia

Computational Toxicology Solutions Segment by Type

On-Premise

Cloud-Based

Computational Toxicology Solutions Segment by Application

Academia

Enterprise

Computational Toxicology Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Computational Toxicology Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Computational Toxicology Solutions key companies, revenue, market share, and recent developments.

3. To split the Computational Toxicology Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Computational Toxicology Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Computational Toxicology Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Computational Toxicology Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computational Toxicology Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computational Toxicology Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computational Toxicology Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Computational Toxicology Solutions industry.

Chapter 3: Detailed analysis of Computational Toxicology Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Computational Toxicology Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Computational Toxicology Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Computational Toxicology Solutions Industry Trends Table 2. Computational Toxicology Solutions Industry Drivers Table 3. Computational Toxicology Solutions Industry Opportunities and Challenges Table 4. Computational Toxicology Solutions Industry Restraints Table 5. Global Computational Toxicology Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Computational Toxicology Solutions Revenue Share by Company (2021-2026) Table 7. Global Computational Toxicology Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Computational Toxicology Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Computational Toxicology Solutions Company, Product Type & Application Table 10. Global Computational Toxicology Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Computational Toxicology Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-Premise Table 15. Significant Companies of Cloud-Based Table 16. Global Computational Toxicology Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Computational Toxicology Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Computational Toxicology Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Computational Toxicology Solutions Sales Value Share by Type (2021-2026) Table 20. Global Computational Toxicology Solutions Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Academia Table 22. Significant Companies of Enterprise Table 23. Global Computational Toxicology Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Computational Toxicology Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Computational Toxicology Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Computational Toxicology Solutions Sales Value Share by Application (2021-2026) Table 27. Global Computational Toxicology Solutions Sales Value Share by Application (2027-2032) Table 28. Global Computational Toxicology Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Computational Toxicology Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Computational Toxicology Solutions Sales Value Share by Region (2021-2026) Table 31. Global Computational Toxicology Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Computational Toxicology Solutions Sales Value Share by Region (2027-2032) Table 33. Global Computational Toxicology Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Computational Toxicology Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Computational Toxicology Solutions Sales Value Market Share by Country (2021-2026) Table 36. Global Computational Toxicology Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Computational Toxicology Solutions Sales Value Market Share by Country (2027-2032) Table 38. Instem (Leadscope) Company Information Table 39. Instem (Leadscope) Business Overview Table 40. Instem (Leadscope) Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Instem (Leadscope) Computational Toxicology Solutions Product Portfolio Table 42. Instem (Leadscope) Recent Development Table 43. Lhasa Limited Company Information Table 44. Lhasa Limited Business Overview Table 45. Lhasa Limited Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Lhasa Limited Computational Toxicology Solutions Product Portfolio Table 47. Lhasa Limited Recent Development Table 48. MultiCASE Company Information Table 49. MultiCASE Business Overview Table 50. MultiCASE Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. MultiCASE Computational Toxicology Solutions Product Portfolio Table 52. MultiCASE Recent Development Table 53. Inotiv Company Information Table 54. Inotiv Business Overview Table 55. Inotiv Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Inotiv Computational Toxicology Solutions Product Portfolio Table 57. Inotiv Recent Development Table 58. Simulations Plus Inc Company Information Table 59. Simulations Plus Inc Business Overview Table 60. Simulations Plus Inc Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Simulations Plus Inc Computational Toxicology Solutions Product Portfolio Table 62. Simulations Plus Inc Recent Development Table 63. Schrodinger Company Information Table 64. Schrodinger Business Overview Table 65. Schrodinger Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Schrodinger Computational Toxicology Solutions Product Portfolio Table 67. Schrodinger Recent Development Table 68. Aclaris Company Information Table 69. Aclaris Business Overview Table 70. Aclaris Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Aclaris Computational Toxicology Solutions Product Portfolio Table 72. Aclaris Recent Development Table 73. Evogene Company Information Table 74. Evogene Business Overview Table 75. Evogene Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Evogene Computational Toxicology Solutions Product Portfolio Table 77. Evogene Recent Development Table 78. Deciphex (Patholytix) Company Information Table 79. Deciphex (Patholytix) Business Overview Table 80. Deciphex (Patholytix) Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Deciphex (Patholytix) Computational Toxicology Solutions Product Portfolio Table 82. Deciphex (Patholytix) Recent Development Table 83. Exscientia Company Information Table 84. Exscientia Business Overview Table 85. Exscientia Computational Toxicology Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Exscientia Computational Toxicology Solutions Product Portfolio Table 87. Exscientia Recent Development Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Computational Toxicology Solutions Product Image Figure 2. Global Computational Toxicology Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Computational Toxicology Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Computational Toxicology Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-Premise Image Figure 8. Cloud-Based Image Figure 9. Global Computational Toxicology Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Computational Toxicology Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Computational Toxicology Solutions Sales Value Share by Type (2021-2032) Figure 12. Academia Image Figure 13. Enterprise Image Figure 14. Global Computational Toxicology Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Computational Toxicology Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Computational Toxicology Solutions Sales Value Share by Application (2021-2032) Figure 17. Global Computational Toxicology Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Computational Toxicology Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Computational Toxicology Solutions Sales Value (2021-2032) & (US$ Million) Figure 20. North America Computational Toxicology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Computational Toxicology Solutions Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Computational Toxicology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Computational Toxicology Solutions Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Computational Toxicology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Computational Toxicology Solutions Sales Value (2021-2032) & (US$ Million) Figure 26. South America Computational Toxicology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Computational Toxicology Solutions Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Computational Toxicology Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Computational Toxicology Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • On-Premise
  • Cloud-Based
Applications
  • Academia
  • Enterprise
Companies covered
  • Instem (Leadscope)
  • Lhasa Limited
  • MultiCASE
  • Inotiv
  • Simulations Plus Inc
  • Schrodinger
  • Aclaris
  • Evogene
  • Deciphex (Patholytix)
  • Exscientia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Computational Toxicology Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Computational Toxicology Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Computational Toxicology Solutions Market Dynamics
  1. 2.1 Computational Toxicology Solutions Industry Trends
  2. 2.2 Computational Toxicology Solutions Industry Drivers
  3. 2.3 Computational Toxicology Solutions Industry Opportunities and Challenges
  4. 2.4 Computational Toxicology Solutions Industry Restraints
3 Computational Toxicology Solutions Market by Company
  1. 3.1 Global Computational Toxicology Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Computational Toxicology Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Computational Toxicology Solutions Company Ranking (2024-2026)
  4. 3.4 Global Computational Toxicology Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Computational Toxicology Solutions Company Product Type and Application
  6. 3.6 Global Computational Toxicology Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Computational Toxicology Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Computational Toxicology Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Computational Toxicology Solutions Market by Type
  1. 4.1 Computational Toxicology Solutions Type Introduction
  2. 4.1.1 On-Premise
  3. 4.1.2 Cloud-Based
  4. 4.2 Global Computational Toxicology Solutions Sales Value by Type
  5. 4.2.1 Global Computational Toxicology Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Computational Toxicology Solutions Sales Value by Type (2021-2032)
  7. 4.2.3 Global Computational Toxicology Solutions Sales Value Share by Type (2021-2032)
5 Computational Toxicology Solutions Market by Application
  1. 5.1 Computational Toxicology Solutions Application Introduction
  2. 5.1.1 Academia
  3. 5.1.2 Enterprise
  4. 5.2 Global Computational Toxicology Solutions Sales Value by Application
  5. 5.2.1 Global Computational Toxicology Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Computational Toxicology Solutions Sales Value by Application (2021-2032)
  7. 5.2.3 Global Computational Toxicology Solutions Sales Value Share by Application (2021-2032)
6 Computational Toxicology Solutions Regional Value Analysis
  1. 6.1 Global Computational Toxicology Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Computational Toxicology Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Computational Toxicology Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Computational Toxicology Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Computational Toxicology Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Computational Toxicology Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Computational Toxicology Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Computational Toxicology Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Computational Toxicology Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Computational Toxicology Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Computational Toxicology Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Computational Toxicology Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Computational Toxicology Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Computational Toxicology Solutions Sales Value Share by Country, 2025 VS 2032
7 Computational Toxicology Solutions Country-level Value Analysis
  1. 7.1 Global Computational Toxicology Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Computational Toxicology Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Computational Toxicology Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Computational Toxicology Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Computational Toxicology Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Computational Toxicology Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Computational Toxicology Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Instem (Leadscope)
  2. 8.1.1 Instem (Leadscope) Company Information
  3. 8.1.2 Instem (Leadscope) Business Overview
  4. 8.1.3 Instem (Leadscope) Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Instem (Leadscope) Computational Toxicology Solutions Product Portfolio
  6. 8.1.5 Instem (Leadscope) Recent Developments
  7. 8.2 Lhasa Limited
  8. 8.2.1 Lhasa Limited Company Information
  9. 8.2.2 Lhasa Limited Business Overview
  10. 8.2.3 Lhasa Limited Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lhasa Limited Computational Toxicology Solutions Product Portfolio
  12. 8.2.5 Lhasa Limited Recent Developments
  13. 8.3 MultiCASE
  14. 8.3.1 MultiCASE Company Information
  15. 8.3.2 MultiCASE Business Overview
  16. 8.3.3 MultiCASE Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MultiCASE Computational Toxicology Solutions Product Portfolio
  18. 8.3.5 MultiCASE Recent Developments
  19. 8.4 Inotiv
  20. 8.4.1 Inotiv Company Information
  21. 8.4.2 Inotiv Business Overview
  22. 8.4.3 Inotiv Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Inotiv Computational Toxicology Solutions Product Portfolio
  24. 8.4.5 Inotiv Recent Developments
  25. 8.5 Simulations Plus Inc
  26. 8.5.1 Simulations Plus Inc Company Information
  27. 8.5.2 Simulations Plus Inc Business Overview
  28. 8.5.3 Simulations Plus Inc Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Simulations Plus Inc Computational Toxicology Solutions Product Portfolio
  30. 8.5.5 Simulations Plus Inc Recent Developments
  31. 8.6 Schrodinger
  32. 8.6.1 Schrodinger Company Information
  33. 8.6.2 Schrodinger Business Overview
  34. 8.6.3 Schrodinger Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Schrodinger Computational Toxicology Solutions Product Portfolio
  36. 8.6.5 Schrodinger Recent Developments
  37. 8.7 Aclaris
  38. 8.7.1 Aclaris Company Information
  39. 8.7.2 Aclaris Business Overview
  40. 8.7.3 Aclaris Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aclaris Computational Toxicology Solutions Product Portfolio
  42. 8.7.5 Aclaris Recent Developments
  43. 8.8 Evogene
  44. 8.8.1 Evogene Company Information
  45. 8.8.2 Evogene Business Overview
  46. 8.8.3 Evogene Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Evogene Computational Toxicology Solutions Product Portfolio
  48. 8.8.5 Evogene Recent Developments
  49. 8.9 Deciphex (Patholytix)
  50. 8.9.1 Deciphex (Patholytix) Company Information
  51. 8.9.2 Deciphex (Patholytix) Business Overview
  52. 8.9.3 Deciphex (Patholytix) Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Deciphex (Patholytix) Computational Toxicology Solutions Product Portfolio
  54. 8.9.5 Deciphex (Patholytix) Recent Developments
  55. 8.10 Exscientia
  56. 8.10.1 Exscientia Company Information
  57. 8.10.2 Exscientia Business Overview
  58. 8.10.3 Exscientia Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Exscientia Computational Toxicology Solutions Product Portfolio
  60. 8.10.5 Exscientia Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst